Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,411 across all filing types
Latest filing 2025-02-28 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Enhertu recommended in EU in post-ET breast cancer
Regulatory Filings Classification · 98% confidence The document is a formal announcement disseminated via RNS (RNS Number : 9298Y) on February 28, 2025. It details a positive opinion from the CHMP (Committee for Medicinal Products for Human Use) regarding the recommendation for approval of the drug Enhertu in the EU for a specific type of breast cancer. This type of announcement, which communicates a significant regulatory or clinical development update, is characteristic of a general regulatory filing or announcement, rather than a full financial report (10-K, IR) or a management discussion (MDA). Since it is a specific regulatory update disseminated through the RNS system and doesn't fit perfectly into other specific categories like Director's Dealing (DIRS) or Dividend Notice (DIV), the most appropriate classification is the general Regulatory Filings category (RNS). The document length is substantial (over 20,000 characters), but its primary function is to disseminate news via the regulatory channel, not to be the comprehensive report itself.
2025-02-28 English
CAMIZESTRANT IMPROVED PFS IN 1L HR+ BREAST CANCER
Regulatory Filings
2025-02-26 English
Camizestrant improved PFS in 1L HR+ breast cancer
Regulatory Filings Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it contains 'inside information' and is provided by 'RNS, the news service of the London Stock Exchange'. The content details positive clinical trial results (SERENA-6 Phase III) for a drug (Camizestrant) and includes quotes from R&D executives and investigators. This format—a press release announcing significant corporate/clinical news via an official regulatory news service—is characteristic of a general regulatory announcement that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a broad regulatory announcement not covered by other specific codes (like DIV, DIRS, MANG), the most appropriate fallback category is Regulatory Filings (RNS). The document length (14,845 chars) is substantial, indicating it is the full announcement, not just a brief notice of publication (RPA).
2025-02-26 English
FILING OF FORM 20-F WITH SEC
Regulatory Filings
2025-02-19 English
Filing of Form 20-F with SEC
Report Publication Announcement Classification · 99% confidence The document is a short announcement (2778 characters) released via RNS (London Stock Exchange news service). The core content states that AstraZeneca filed its '2024 Annual Report on Form 20-F with the US Securities and Exchange Commission (SEC)' and directs the reader to the SEC website or the company website to view the document. According to Rule 2 ('MENU VS MEAL' Rule), when a document announces the publication of a report (like an Annual Report/20-F) rather than containing the full report itself, it should be classified as a Report Publication Announcement (RPA). The presence of the RNS Number and the explicit statement about filing/publishing the report confirms this classification.
2025-02-19 English
IRANNOTICE
Regulatory Filings
2025-02-18 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.